-
Targeting proteins to membranes: structure of the signal recognition particle.
Curr Opin Struct Biol. 2005 Apr;15(2):213-20
PMID: 15837181
-
Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
J Biol Chem. 2005 May 13;280(19):18573-8
PMID: 15781449
-
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
J Virol. 2005 Aug;79(15):9579-87
PMID: 16014920
-
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9854-9
PMID: 16000409
-
Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages.
J Biol Chem. 2005 Aug 12;280(32):29364-73
PMID: 15955815
-
Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11444-9
PMID: 16076960
-
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
J Virol. 2005 Sep;79(17):10978-87
PMID: 16103149
-
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
Virology. 2005 Sep 1;339(2):281-8
PMID: 15993456
-
Nonrandom packaging of host RNAs in moloney murine leukemia virus.
J Virol. 2005 Nov;79(21):13528-37
PMID: 16227273
-
Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
J Virol. 2006 Jan;80(2):875-82
PMID: 16378989
-
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.
Nucleic Acids Res. 2006;34(1):89-95
PMID: 16407327
-
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.
Curr Biol. 2006 Mar 7;16(5):480-5
PMID: 16527742
-
7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles.
RNA. 2006 Apr;12(4):542-6
PMID: 16489186
-
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.
Virology. 2006 Jun 5;349(2):290-9
PMID: 16530799
-
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
PLoS Pathog. 2006 May;2(5):e41
PMID: 16699599
-
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
J Virol. 2007 Jul;81(13):7238-48
PMID: 17428847
-
Inhibition of hepatitis B virus replication by APOBEC3G.
Science. 2004 Mar 19;303(5665):1829
PMID: 15031497
-
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
Nat Struct Mol Biol. 2004 May;11(5):435-42
PMID: 15098018
-
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Nucleic Acids Res. 2004;32(8):2421-9
PMID: 15121899
-
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
J Virol. 2004 Jun;78(11):6073-6
PMID: 15141007
-
The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity.
J Mol Med (Berl). 2004 Apr;82(4):232-9
PMID: 15168680
-
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.
EMBO J. 2004 Jun 16;23(12):2451-8
PMID: 15152192
-
The interaction between HIV-1 Gag and APOBEC3G.
J Biol Chem. 2004 Aug 6;279(32):33177-84
PMID: 15159405
-
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Curr Biol. 2004 Aug 10;14(15):1385-91
PMID: 15296757
-
Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
Curr Biol. 2004 Aug 10;14(15):1392-6
PMID: 15296758
-
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein.
J Biol Chem. 2004 Aug 13;279(33):34083-6
PMID: 15215254
-
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
J Biol Chem. 2004 Aug 20;279(34):35822-8
PMID: 15210704
-
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles.
Biochem Biophys Res Commun. 2004 Aug 27;321(3):566-73
PMID: 15358144
-
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
Virology. 2004 Oct 25;328(2):163-8
PMID: 15464836
-
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
J Virol. 2004 Nov;78(21):11841-52
PMID: 15479826
-
APOBEC3G incorporation into human immunodeficiency virus type 1 particles.
J Virol. 2004 Nov;78(21):12058-61
PMID: 15479846
-
Nucleic acid and proteins isolated from the Rauscher mouse leukemia virus (MLV).
Proc Natl Acad Sci U S A. 1966 Jan;55(1):219-27
PMID: 5220869
-
The low molecular weight RNAs of Rous sarcoma virus. II. The 7 S RNA.
Virology. 1970 Dec;42(4):927-37
PMID: 4321311
-
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8780-5
PMID: 16728505
-
A zinc-binding region in Vif binds Cul5 and determines cullin selection.
J Biol Chem. 2006 Jun 23;281(25):17259-65
PMID: 16636053
-
APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
J Biol Chem. 2006 Jun 23;281(25):16837-41
PMID: 16648136
-
APOBEC3 proteins inhibit human LINE-1 retrotransposition.
J Biol Chem. 2006 Aug 4;281(31):22161-72
PMID: 16735504
-
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
J Virol. 2006 Sep;80(17):8450-8
PMID: 16912295
-
The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
J Biol Chem. 2006 Sep 29;281(39):29105-19
PMID: 16887808
-
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15588-93
PMID: 17030807
-
Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
J Virol. 2006 Dec;80(23):11710-22
PMID: 16971427
-
Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
FASEB J. 2007 Jan;21(1):217-22
PMID: 17135358
-
Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
J Virol. 2007 Mar;81(5):2165-78
PMID: 17166910
-
Protein-induced conformational changes of RNA during the assembly of human signal recognition particle.
J Mol Biol. 2007 Mar 16;367(1):187-203
PMID: 17254600
-
Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.
J Virol. 2007 Apr;81(8):3807-15
PMID: 17267497
-
Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
J Biol Chem. 2007 Apr 20;282(16):11667-75
PMID: 17272283
-
Model structure of human APOBEC3G.
PLoS One. 2007;2(4):e378
PMID: 17440614
-
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
J Virol. 2007 May;81(10):5000-13
PMID: 17344295
-
Characterization of ribonucleic acid from visna virus.
J Virol. 1971 May;7(5):582-7
PMID: 4997549
-
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.
J Virol. 2007 Jul;81(13):7099-110
PMID: 17428871
-
An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
Genomics. 2002 Mar;79(3):285-96
PMID: 11863358
-
Crystal structure of SRP19 in complex with the S domain of SRP RNA and its implication for the assembly of the signal recognition particle.
Mol Cell. 2002 Jun;9(6):1251-61
PMID: 12086622
-
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
Nature. 2002 Aug 8;418(6898):646-50
PMID: 12167863
-
Hypermutation of HIV-1 DNA in the absence of the Vif protein.
Science. 2003 May 16;300(5622):1112
PMID: 12750511
-
DNA deamination mediates innate immunity to retroviral infection.
Cell. 2003 Jun 13;113(6):803-9
PMID: 12809610
-
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
Nature. 2003 Jul 3;424(6944):94-8
PMID: 12808465
-
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Nature. 2003 Jul 3;424(6944):99-103
PMID: 12808466
-
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
Cell. 2003 Jul 11;114(1):21-31
PMID: 12859895
-
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Mol Cell. 2003 Sep;12(3):591-601
PMID: 14527406
-
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Nat Med. 2003 Nov;9(11):1404-7
PMID: 14528300
-
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Nat Med. 2003 Nov;9(11):1398-403
PMID: 14528301
-
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Science. 2003 Nov 7;302(5647):1056-60
PMID: 14564014
-
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Curr Biol. 2003 Nov 11;13(22):2009-13
PMID: 14614829
-
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
J Virol. 2004 Feb;78(4):2072-81
PMID: 14747572
-
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.
J Virol. 1974 Jul;14(1):152-61
PMID: 4134468
-
Properties of feline leukemia virus. III. Analysis of the RNA.
J Virol. 1975 Sep;16(3):535-45
PMID: 169389
-
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis.
J Virol. 1977 Mar;21(3):1031-41
PMID: 66325
-
Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA.
J Virol. 1979 Jan;29(1):328-35
PMID: 219227
-
Variable tRNA content in HIV-1IIIB.
Biochem Biophys Res Commun. 1992 Jun 30;185(3):1005-15
PMID: 1627125
-
Retroviral restriction by APOBEC proteins.
Nat Rev Immunol. 2004 Nov;4(11):868-77
PMID: 15516966
-
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.
Genes Dev. 2004 Dec 1;18(23):2861-6
PMID: 15574592
-
Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.
Genes Dev. 2004 Dec 1;18(23):2867-72
PMID: 15574593
-
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
J Biol Chem. 2004 Dec 17;279(51):53379-86
PMID: 15466872
-
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Nature. 2005 Jan 27;433(7024):430-3
PMID: 15674295
-
Editing at the crossroad of innate and adaptive immunity.
Science. 2005 Feb 18;307(5712):1061-5
PMID: 15718460
-
Complementary function of the two catalytic domains of APOBEC3G.
Virology. 2005 Mar 15;333(2):374-86
PMID: 15721369
-
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
Nucleic Acids Res. 2005;33(6):1913-23
PMID: 15809227
-
Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
Curr Biol. 2005 Apr 12;15(7):661-6
PMID: 15823539
-
Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.
J Virol. 2005 May;79(9):5870-4
PMID: 15827203